Previous 10 | Next 10 |
Pulmatrix (NASDAQ: PULM ) prices its previously public offering of an aggregate of 10.7M units at a price of $1.35/unit, for expected gross proceeds of ~$14.4M. Each unit is comprised of one share of common stock and one warrant to purchase one share of common stock. More news on: Pulmat...
LEXINGTON, Mass. , April 3, 2019 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix," the "Company," "we," "our" or "us") (NASDAQ: PULM) today announced the pricing of its previously announced underwritten public offering of an aggregate of 10,666,666 units at a price to the public of $1.35 pe...
Gainers: Ocean Power Technologies (NASDAQ: OPTT ) +176% . Netshoes (Cayman) (NYSE: NETS ) +23% . Evogene (NASDAQ: EVGN ) +22% . Zynerba Pharmaceuticals (NASDAQ: ZYNE ) +21% . DMC Global (NASDAQ: BOOM ) +19% . Fuel Tech (NASDAQ: FTEK ) +18% . VivoPower International (NASDAQ: VVP...
Energy Focus (NASDAQ: EFOI ) -52% on Q4 earnings . More news on: Energy Focus, Inc., Evoke Pharma, Inc., Apyx Medical Corporation, Stocks on the move, Read more ...
Advaxis (NASDAQ: ADXS ) +40% on positive ADXS-NEO data . More news on: Advaxis, Inc., Pulmatrix, Inc., Evoke Pharma, Inc., Stocks on the move, Read more ...
LEXINGTON, Mass. , April 1, 2019 /PRNewswire/ -- Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease, announced today its entry into a Binding Term Sheet with Cipla Techno...
LEXINGTON, Mass. , March 14, 2019 /PRNewswire/ -- Pulmatrix, Inc . (NASDAQ: PULM) announced today that members of its management team will present/participate in investor meetings at the following upcoming conferences: Oppenheimer's 29th Annual Healthcare Conference Date: Tuesday, M...
LEXINGTON, Mass. , March 12, 2019 /PRNewswire/ -- Pulmatrix, Inc . (NASDAQ: PULM) announced today that it received a letter from the listing qualifications department staff of The NASDAQ Stock Market LLC, stating that the Company has regained compliance with NASDAQ's minimum $1.00 ...
Gainers: Bio-Path Holdings (NASDAQ: BPTH ) +201% . Seelos Therapeutics (NASDAQ: SEEL ) +79% . ArQule (NASDAQ: ARQL ) +66% . Altimmune (NASDAQ: ALT ) +60% . Rosetta Stone (NYSE: RST ) +31% . Calumet Specialty Products Partners (NASDAQ: CLMT ) +29% . Cleveland BioLabs (NASDAQ: CB...
Pulmatrix (NASDAQ: PULM ): FY GAAP EPS of -$4.98. Revenue of $0.15M (-55.9% Y/Y) Press Release More news on: Pulmatrix, Inc., Earnings news and commentary, Healthcare stocks news, ,
News, Short Squeeze, Breakout and More Instantly...
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation PR Newswire Cross license involves Pulmatrix iSPERSE™ technology and MannKind's Cricket ® inhalation device. Pulmatrix transferring leased building,...
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) PR Newswire Orally Inhaled PUR3100 is associated with rapid systemic PK within the therapeutic window and a mean time to Cmax matching intravenously (IV) a...